These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35612849)

  • 21. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mohs micrographic surgery in rare cutaneous tumors: a retrospective study at a Brazilian tertiary university hospital.
    Buffo TH; Stelini RF; Serrano JYM; Pontes LT; Magalhães RF; de Moraes AM
    An Bras Dermatol; 2023; 98(1):36-46. PubMed ID: 36369200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
    Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
    Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demographic and Tumor Characteristics of Patients Younger Than 50 Years With Nonmelanoma Skin Cancer Referred for Mohs Micrographic Surgery.
    Quatrano NA; Mu EW; Orbuch DE; Haimovic A; Geronemus RG; Brauer JA
    J Drugs Dermatol; 2018 May; 17(5):499-505. PubMed ID: 29742179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
    Fantini BC; Bueno Filho R; Chahud F; Souza CDS
    J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study.
    Chren MM; Torres JS; Stuart SE; Bertenthal D; Labrador RJ; Boscardin WJ
    Arch Dermatol; 2011 May; 147(5):540-6. PubMed ID: 21576572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mohs micrographic surgery concordance between Mohs surgeons and dermatopathologists.
    Semkova K; Mallipeddi R; Robson A; Palamaras I
    Dermatol Surg; 2013 Nov; 39(11):1648-52. PubMed ID: 24581313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantity and characteristics of flap or graft repairs for skin cancer on the nose or ears: a comparison between Mohs micrographic surgery and plastic surgery.
    Hill D; Kim K; Mansouri B; Sager L; Housewright C
    Cutis; 2019 May; 103(5):284-287. PubMed ID: 31233572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
    Cerci FB; Kubo EM; Werner B; Tolkachjov SN
    J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer.
    Cortés-Peralta EC; Ocampo-Candiani J; Vázquez-Martínez OT; Gutiérrez-Villarreal IM; Miranda-Maldonado I; Garza-Rodríguez V
    Actas Dermosifiliogr (Engl Ed); 2018; 109(1):47-51. PubMed ID: 29066323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
    Ratner D; Bagiella E
    Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-Mohs micrographic surgical margin tissue evaluation with permanent histopathologic sections.
    Campbell RM; Barrall D; Wilkel C; Robinson-Bostom L; Dufresne RG
    Dermatol Surg; 2005 Jun; 31(6):655-8; discussion 658. PubMed ID: 15996415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery.
    Batra RS; Kelley LC
    Arch Dermatol; 2002 Aug; 138(8):1043-51. PubMed ID: 12164742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers.
    Ebede TL; Lee EH; Dusza SW; Busam KJ; Nehal KS
    Dermatol Surg; 2012 Oct; 38(10):1631-8. PubMed ID: 22958072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MOHS micrographic surgery for head and neck nonmelanoma skin cancer: An approach for ENT surgeons.
    Castanheira A; Boaventura P; Soares P; Vieira F; Lopes JM; Mota A
    Dermatol Ther; 2021 Jan; 34(1):e14661. PubMed ID: 33301226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Description of Patients Undergoing Mohs Surgery in Spain: Initial Report on Data From the Spanish Registry of Mohs Surgery (REGESMOHS).
    Ruiz-Salas V; Garcés JR; Miñano Medrano R; Alonso-Alonso T; Rodríguez-Prieto MÁ; López-Estebaranz JL; Sanmartín-Jiménez O; Guillén Barona C; Delgado Jiménez Y; Toll-Abelló A; Vargas Diez E; Ciudad Blanco C; Alfaro Rubio A; Allende Markixana I; de Eusebio Murillo E; Manubens-Mercadé E; Vázquez-Veiga H; Barchino Ortiz L; García-Doval I; Redondo Bellón P
    Actas Dermosifiliogr; 2015 Sep; 106(7):562-8. PubMed ID: 26028578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Horizontal histological sections in the preliminary evaluation of basal cell carcinoma submitted to Mohs micrographic surgery.
    Portela PS; Teixeira DA; Machado CDAS; Pinhal MAS; Paschoal FM
    An Bras Dermatol; 2019; 94(6):671-676. PubMed ID: 31789269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous carcinoma with mixed histology: a potential etiology for skin cancer recurrence and an indication for Mohs microscopically controlled surgical excision.
    Cohen PR; Schulze KE; Nelson BR
    South Med J; 2005 Jul; 98(7):740-7. PubMed ID: 16108247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary Mohs surgery applications.
    Minton TJ
    Curr Opin Otolaryngol Head Neck Surg; 2008 Aug; 16(4):376-80. PubMed ID: 18626258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chren MM; Sahay AP; Bertenthal DS; Sen S; Landefeld CS
    J Invest Dermatol; 2007 Jun; 127(6):1351-7. PubMed ID: 17301830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.